Efficacy and Pharmacokinetics of Once Daily Prolonged Release Tacrolimus in Calcineurin Inhibitor Dependent Steroid-Sensitive Nephrotic Syndrome: A Pilot Study
Srinivasavaradan Govindarajan(All India Institute of Medical Sciences), Arvind Bagga(All India Institute of Medical Sciences), Pankaj Hari(Indian Council of Medical Research), Aditi Sinha
Cited by 0
Related Papers
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203